Published in Cancer Weekly, May 26th, 1997
Researchers from the Centre Claudius Regaud, France, and the University of Pittsburgh, Pennsylvania, have enhanced the anticancer immune stimulating effect of the costimulatory molecule B7.1 by creating a three-way vaccine. Results from in vivo experiments with this tri partner vaccine were presented by V. Doin-Echinard at the American Association for Cancer Research conference, held April 12-16, 1997, in San Diego, California.
"We have shown here the [potential] of...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cancer Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.